COMPANY SIGNED A NON-BINDING TERM SHEET FOR A SECURITY EXCHANGE BETWEEN THE PARTIES TEL AVIV, ISRAEL, NOV. 05, 2025 (GLOBE NEWSWIRE) -- VIEWBIX INC. (NASDAQ: VBIX) (“VIEWBIX” OR THE “COMPANY”), A GLOBAL DEVELOPER OF AD-TECH INNOVATIVE TECHNOLOGIES, TODAY ANNOUNCED THE SIGNING OF A NON-BINDING TERM SHEET OUTLINING THE PROPOSED TERMS FOR THE ACQUISITION OF QUANTUM X LABS LTD. (“QUANTUM X LABS” AND THE “ACQUISITION”).
VBIX
• Nov. 5, 2025
SOUTHLAKE, TEXAS , NOV. 5, 2025 /PRNEWSWIRE/ -- SABRE CORPORATION ("SABRE") (NASDAQ: SABR) TODAY ANNOUNCED FINANCIAL RESULTS FOR THE QUARTER ENDED SEPTEMBER 30, 2025. SABRE HAS POSTED ITS THIRD QUARTER 2025 EARNINGS RELEASE AND EARNINGS PRESENTATION TO ITS INVESTOR RELATIONS WEBPAGE AT INVESTORS.SABRE.COM/FINANCIAL-INFORMATION/QUARTERLY RESULTS.
SABR
• Nov. 5, 2025
ADVANCES 45% EQUITY SALE AT SEMPRA INFRASTRUCTURE PARTNERS EXPECT 30%+ INCREASE IN ONCOR'S 5-YEAR CAPITAL PLAN SAN DIEGO , NOV. 5, 2025 /PRNEWSWIRE/ -- SEMPRA (NYSE: SRE) TODAY REPORTED THIRD-QUARTER 2025 EARNINGS, PREPARED IN ACCORDANCE WITH GENERALLY ACCEPTED ACCOUNTING PRINCIPLES (GAAP), OF $77 MILLION OR $0.12 PER DILUTED SHARE, COMPARED TO THIRD-QUARTER 2024 GAAP EARNINGS OF $638 MILLION OR $1.00 PER DILUTED SHARE. ON AN ADJUSTED BASIS, THIRD-QUARTER 2025 EARNINGS WERE $728 MILLION OR $1.11 PER DILUTED SHARE, COMPARED TO $566 MILLION OR $0.89 PER DILUTED SHARE IN 2024.
SRE
• Nov. 5, 2025
BASE SHELF PROSPECTUS IS ACCESSIBLE, AND FINAL PROSPECTUS SUPPLEMENT WILL BE ACCESSIBLE WITHIN TWO BUSINESS DAYS, ON SEDAR+ AND ON EDGAR TORONTO, ONTARIO / ACCESS NEWSWIRE / NOVEMBER 5, 2025 / ELECTROVAYA INC. ("ELECTROVAYA" OR THE "COMPANY") (NASDAQ:ELVA)(TSX:ELVA), A LEADING LITHIUM-ION BATTERY TECHNOLOGY AND MANUFACTURING COMPANY, ANNOUNCED TODAY THE PRICING OF ITS PREVIOUSLY ANNOUNCED PUBLIC OFFERING (THE "OFFERING") OF 4,700,000 COMMON SHARES OF THE COMPANY ("COMMON SHARES") AT A PRICE TO THE PUBLIC OF US$5.20 PER COMMON SHARE. THE COMPANY HAS GRANTED THE UNDERWRITERS A 30-DAY OPTION TO PURCHASE UP TO AN ADDITIONAL 705,000 COMMON SHARES AT THE PUBLIC OFFERING PRICE, LESS UNDERWRITING DISCOUNTS AND COMMISSIONS.
ELVA
• Nov. 5, 2025
SAN JOSE, CALIF.--(BUSINESS WIRE)--POWER INTEGRATIONS ANNOUNCED FINANCIAL RESULTS FOR THE THIRD QUARTER OF 2025.
POWI
• Nov. 5, 2025
TORONTO, NOV. 05, 2025 (GLOBE NEWSWIRE) -- STACK CAPITAL GROUP INC., (“STACK CAPITAL” OR THE “COMPANY”) (TSX:STCK; TSX:STCK.WT.A; TSX:STCK.WT.B) TODAY ANNOUNCED ITS FINANCIAL RESULTS FOR THE QUARTER ENDED SEPTEMBER 30, 2025. STACK CAPITAL REPORTS ALL AMOUNTS IN CANADIAN DOLLARS UNLESS OTHERWISE STATED.
STCGF
• Nov. 5, 2025
THE ESC M&PD MEETING BRINGS TOGETHER THE WORLD'S EXPERTS WORKING TO IMPROVE THE TREATMENT OF MYOCARDITIS AND PERICARDITIS. PRESENTATION TO PROVIDE COMPREHENSIVE FINDINGS FROM THE ARCHER TRIAL FOLLOWING THE REPORTING OF TOPLINE RESULTS DEMONSTRATING A NOTABLE IMPROVEMENT IN EXTRACELLULAR VOLUME AND A SIGNIFICANT REDUCTION IN LEFT VENTRICULAR MASS.
CRDL
• Nov. 5, 2025
THIRD QUARTER 2025 CONSUMER CREDIT TRENDS INDICATE MODERATE DEBT GROWTH FOR AUTO AND STUDENT LOANS ATLANTA , NOV. 5, 2025 /PRNEWSWIRE/ -- EQUIFAX ® (NYSE: EFX) HAS RELEASED ITS MARKET PULSE THIRD QUARTER U.S. CONSUMER CREDIT TRENDS , WHICH INCLUDES U.S. NATIONAL CONSUMER CREDIT DATA AND TRENDS THROUGH SEPTEMBER 2025 SOURCED FROM EQUIFAX DATA. ACCORDING TO EQUIFAX, DELINQUENCY ON TOTAL U.S. CONSUMER DEBT INCHED UP TO 1.562% IN SEPTEMBER, A SLIGHT INCREASE FROM 1.517% AT END OF THE SECOND QUARTER IN JUNE 2025.
EFX
• Nov. 5, 2025
AMSTERDAM--(BUSINESS WIRE)--NEBIUS TODAY UNVEILED NEBIUS TOKEN FACTORY, A PRODUCTION INFERENCE PLATFORM THAT ENABLES VERTICAL AI COMPANIES AND DIGITAL ENTERPRISES TO DEPLOY AND OPTIMIZE OPEN-SOURCE AND CUSTOM MODELS AT SCALE AND WITH ENTERPRISE-GRADE RELIABILITY AND CONTROL. BUILT ON NEBIUS'S FULL-STACK AI INFRASTRUCTURE, NEBIUS TOKEN FACTORY BRINGS TOGETHER HIGH-PERFORMANCE INFERENCE, POST-TRAINING AND FINE-GRAINED ACCESS MANAGEMENT INTO A SINGLE GOVERNED PLATFORM. IT SUPPORTS ALL MAJOR OPEN M.
NBIS
• Nov. 5, 2025
TORRENT CAPITAL LTD. HAS SOLD ITS REMAINING SOLANA (SOL) HOLDINGS, REALIZING GROSS PROCEEDS OF APPROXIMATELY $12.4 MILLION CAD AND STRENGTHENING ITS CASH POSITION.
TRRPF
• Nov. 5, 2025
STOCK MARKET SYMBOLS GIB.A (TSX) GIB (NYSE) CGI.COM/NEWSROOM FOURTH QUARTER REVENUE UP 9.7% YEAR-OVER-YEAR ANNOUNCES 13% INCREASE TO ITS DIVIDEND Q4-F2025 PERFORMANCE HIGHLIGHTS REVENUE OF $4.01 BILLION, UP 9.7% YEAR-OVER-YEAR OR 5.5% YEAR-OVER-YEAR IN CONSTANT CURRENCY1; EARNINGS BEFORE INCOME TAXES OF $516.2 MILLION, DOWN 12.9% YEAR-OVER-YEAR, FOR A MARGIN1 OF 12.9%; ADJUSTED EARNINGS BEFORE INTEREST AND TAXES1,2 OF $667.4 MILLION, UP 11.2% YEAR-OVER-YEAR, FOR A MARGIN1 OF 16.6%; NET EARNINGS OF $381.4 MILLION FOR A MARGIN1 OF 9.5%, AND DILUTED EPS OF $1.72, DOWN 9.9% YEAR-OVER-YEAR; ADJUSTED NET EARNINGS1,2 OF $471.7 MILLION FOR A MARGIN1 OF 11.8%, AND ADJUSTED DILUTED EPS1,2 OF $2.13, UP 10.9% YEAR-OVER-YEAR; CASH PROVIDED BY OPERATING ACTIVITIES OF $663.0 MILLION, REPRESENTING 16.5% OF REVENUE1; AND BOOKINGS1 OF $4.79 BILLION, FOR A BOOK-TO-BILL RATIO1 OF 119.2%. F2025 PERFORMANCE HIGHLIGHTS REVENUE OF $15.91 BILLION, UP 8.4% YEAR-OVER-YEAR OR 4.6% YEAR-OVER-YEAR IN CONSTANT CURRENCY1; EARNINGS BEFORE INCOME TAXES OF $2,242.2 MILLION, DOWN 2.1% YEAR-OVER-YEAR, FOR A MARGIN1 OF 14.1%; ADJUSTED EARNINGS BEFORE INTEREST AND TAXES1,3 OF $2,610.9 MILLION, UP 8.1% YEAR-OVER-YEAR, FOR A MARGIN1 OF 16.4%; NET EARNINGS OF $1,658.3 MILLION, DOWN 2.0% YEAR-OVER-YEAR, FOR A MARGIN1 OF 10.4%, AND DILUTED EPS OF $7.35, UP 0.5% YEAR-OVER-YEAR; ADJUSTED NET EARNINGS1,3 OF $1,871.5 MILLION, UP 6.0% YEAR-OVER-YEAR, OR A MARGIN1 OF 11.8%, AND ADJUSTED DILUTED EPS1,3 OF $8.30, UP 8.9% YEAR-OVER-YEAR; CASH PROVIDED BY OPERATING ACTIVITIES OF $2,234.2 MILLION, REPRESENTING 14.0% OF REVENUE1; BOOKINGS1 OF $17.57 BILLION, FOR A BOOK-TO-BILL RATIO1 OF 110.4%; AND BACKLOG1 OF $31.45 BILLION OR 2.0X ANNUAL REVENUE.
GIB
• Nov. 5, 2025
FDA OPEN TO POOLING DATA FROM ONGOING PHASE I/II STUDIES OF LX2006 WITH DATA FROM PIVOTAL TRIAL, AND TO EARLIER CO-PRIMARY ENDPOINT ASSESSMENT, TO SUPPORT A BIOLOGICS LICENSE APPLICATION FDA APPROVED COMPARABILITY REPORT BETWEEN LX2006 HEK AND SF9 MANUFACTURING PROCESSES IN NOVEMBER 2025, ENDORSING USE OF SF9 FINAL COMMERCIAL MANUFACTURING PROCESS TO BEGIN DOSING PATIENTS IN UPCOMING PIVOTAL STUDY LX2006 INTERIM CLINICAL DATA SHOW CLINICALLY MEANINGFUL IMPROVEMENTS ACROSS CARDIAC AND NEUROLOGIC MEASURES OF FRIEDREICH ATAXIA, INCLUDING LEFT VENTRICULAR MASS INDEX AND THE MODIFIED FRIEDREICH ATAXIA RATING SCALE COMPLETED ENROLLMENT OF LX2020 HEROIC-PKP2 PHASE I/II TRIAL WITH TEN PARTICIPANTS DOSED; INTERIM DATA FROM LOW-DOSE COHORT REPORTED AND ADDITIONAL CLINICAL DATA FROM HIGH-DOSE COHORTS ON TRACK FOR JANUARY 2026 $154 MILLION EQUITY FINANCING TO SUPPORT LX2006 REGISTRATIONAL ACTIVITIES AND FURTHER DEVELOPMENT OF CARDIAC PIPELINE; IN ADDITION TO Q3-25 END CASH, CASH EQUIVALENTS AND INVESTMENTS, EXPECTED TO FUND OPERATIONS INTO 2028 NEW YORK, NOV. 05, 2025 (GLOBE NEWSWIRE) -- LEXEO THERAPEUTICS, INC. (NASDAQ: LXEO), A CLINICAL STAGE GENETIC MEDICINE COMPANY DEDICATED TO PIONEERING NOVEL TREATMENTS FOR CARDIOVASCULAR DISEASES, TODAY PROVIDED BUSINESS UPDATES ACROSS ITS PORTFOLIO AND REPORTED THIRD QUARTER 2025 FINANCIAL RESULTS. “WE CONTINUE TO BUILD SIGNIFICANT MOMENTUM ACROSS OUR CARDIAC PIPELINE, AND THE RECENT FINANCING STRENGTHENS OUR ABILITY TO EXECUTE ON ESSENTIAL MANUFACTURING AND COMMERCIAL ACTIVITIES FOR LX2006 AS WE LOOK TOWARDS REGISTRATIONAL READINESS,” SAID R.
LXEO
• Nov. 5, 2025
TORONTO, ON / ACCESS NEWSWIRE / NOVEMBER 5, 2025 / STERLING METALS CORP. (TSXV:SAG)(OTCQB:SAGGF) ("STERLING" OR THE "COMPANY") IS PLEASED TO ANNOUNCE A NON-BROKERED PRIVATE PLACEMENT OF UP TO 3,088,888 UNITS (EACH, A "UNIT") AT A PRICE OF $1.50 PER UNIT AND UP TO 2,333,334 CHARITY FLOW-THROUGH UNITS (EACH, A "CHARITY FT UNIT") AT A PRICE $2.30 PER CHARITY FT UNIT FOR AGGREGATE GROSS PROCEEDS OF UP TO $10,000,000.20(THE "OFFERING"). EACH UNIT SHALL BE COMPRISED OF ONE COMMON SHARE (EACH, A "COMMON SHARE") IN THE CAPITAL OF THE COMPANY AND ONE-HALF OF ONE COMMON SHARE PURCHASE WARRANT (EACH WHOLE WARRANT, A "WARRANT") OF THE COMPANY.
SAGGF
• Nov. 5, 2025
BOSTON--(BUSINESS WIRE)--VERASTEM ONCOLOGY (NASDAQ: VSTM), A BIOPHARMACEUTICAL COMPANY COMMITTED TO ADVANCING NEW MEDICINES FOR PATIENTS WITH RAS/MAPK PATHWAY-DRIVEN CANCERS, TODAY ANNOUNCED THAT ITS MANAGEMENT TEAM IS SCHEDULED TO PARTICIPATE AND PRESENT AT THE FOLLOWING INVESTOR CONFERENCES IN NOVEMBER: GUGGENHEIM HEALTHCARE CONFERENCE 2025: FIRESIDE CHAT ON TUESDAY, NOVEMBER 11 AT 1:00 PM ET JEFFERIES GLOBAL HEALTHCARE CONFERENCE IN LONDON: FIRESIDE CHAT ON WEDNESDAY, NOVEMBER 19 AT 2:30 PM.
VSTM
• Nov. 5, 2025
COLUMBUS, OHIO--(BUSINESS WIRE)--INSTALLED BUILDING PRODUCTS, INC. (THE "COMPANY" OR "IBP") (NYSE: IBP), AN INDUSTRY-LEADING INSTALLER OF INSULATION AND COMPLEMENTARY BUILDING PRODUCTS, TODAY ANNOUNCED RESULTS FOR THE THIRD QUARTER ENDED SEPTEMBER 30, 2025. THIRD QUARTER 2025 HIGHLIGHTS (COMPARISONS ARE TO PRIOR YEAR PERIOD) NET REVENUE INCREASED 2.3% TO AN ALL-TIME RECORD OF $778.2 MILLION INSTALLATION REVENUE INCREASED 1.0% TO $721.1 MILLION, INCLUDING SALES FROM IBP'S RECENT ACQUISITIONS OTH.
IBP
• Nov. 5, 2025
PHOENIX--(BUSINESS WIRE)--FREEPORT (NYSE: FCX) ANNOUNCED TODAY THAT A. CORY STEVENS HAS BEEN NAMED PRESIDENT AND CHIEF OPERATING OFFICER OF FREEPORT AMERICAS, EFFECTIVE DECEMBER 1, 2025. STEVENS JOINED FREEPORT IN 1997 AND HAS HELD MULTIPLE LEADERSHIP ROLES AT THE COMPANY'S NORTH AND SOUTH AMERICA OPERATIONS AND MOST RECENTLY LED THE TEAM RESPONSIBLE FOR DEVELOPING FREEPORT'S SMELTER PROJECT IN INDONESIA. HE CURRENTLY LEADS FCX'S CENTRALIZED TECHNICAL ORGANIZATION, WITH RESPONSIBILITY FOR A BRO.
FCX
• Nov. 5, 2025
LOUISVILLE, KY.--(BUSINESS WIRE)--TURNING POINT BRANDS, INC. (“TPB” OR THE “COMPANY”) (NYSE: TPB), A MANUFACTURER, MARKETER AND DISTRIBUTOR OF BRANDED CONSUMER PRODUCTS, INCLUDING ALTERNATIVE SMOKING ACCESSORIES AND CONSUMABLES WITH ACTIVE INGREDIENTS, TODAY ANNOUNCED FINANCIAL RESULTS FOR THE THIRD QUARTER ENDED SEPTEMBER 30, 2025. Q3 2025 VS. Q3 2024 TOTAL CONSOLIDATED NET SALES INCREASED 31.2% TO $119.0 MILLION STOKER'S SEGMENT NET SALES INCREASED 80.8% ZIG-ZAG SEGMENT NET SALES DECREASED 10.
TPB
• Nov. 5, 2025
CHICAGO--(BUSINESS WIRE)--ALIGHT, INC. (NYSE: ALIT), A LEADING CLOUD-BASED HUMAN CAPITAL AND TECHNOLOGY-ENABLED SERVICES PROVIDER, TODAY REPORTED RESULTS FOR THE THIRD QUARTER ENDED SEPTEMBER 30, 2025. “I AM PLEASED WITH OUR ABILITY TO DELIVER ENHANCED OUTCOMES FOR CLIENTS AND THEIR PEOPLE, WITH PARTICIPANT SATISFACTION AT RECORD LEVELS SINCE THE END OF OUR TECHNOLOGY TRANSFORMATION," SAID CEO DAVE GUILMETTE. “WE HAVE SEEN A FAVORABLE STEP-CHANGE IN ACCELERATING OUR CLIENT MANAGEMENT AND DELIVE.
ALIT
• Nov. 5, 2025
SINGAPORE--(BUSINESS WIRE)--SEAGATE TECHNOLOGY HOLDINGS PLC (NASDAQ: STX) (“SEAGATE” OR “US”) AND SEAGATE HDD CAYMAN, A SUBSIDIARY OF SEAGATE (“SEAGATE HDD”), TODAY ANNOUNCED THAT ON NOVEMBER 4, 2025, THEY ENTERED INTO SEPARATE, PRIVATELY NEGOTIATED EXCHANGE AGREEMENTS WITH A LIMITED NUMBER OF HOLDERS OF SEAGATE HDD'S 3.50% EXCHANGEABLE SENIOR NOTES DUE 2028 (THE “NOTES”) TO EXCHANGE (COLLECTIVELY, THE “EXCHANGES”) $500 MILLION PRINCIPAL AMOUNT OF NOTES FOR CONSIDERATION CONSISTING OF AN AGGREG.
STX
• Nov. 5, 2025
DALLAS--(BUSINESS WIRE)---- $SNDA--SONIDA SENIOR LIVING, INC. (“SONIDA” OR THE “COMPANY”) (NYSE: SNDA), A LEADING OWNER, OPERATOR AND INVESTOR IN SENIOR LIVING COMMUNITIES, AND CNL HEALTHCARE PROPERTIES, INC. (“CHP”), A PUBLIC NON-TRADED REAL ESTATE INVESTMENT TRUST (“REIT”) WHICH OWNS A NATIONAL PORTFOLIO OF HIGH-QUALITY SENIOR HOUSING COMMUNITIES, TODAY ANNOUNCED A DEFINITIVE MERGER AGREEMENT (THE “MERGER AGREEMENT”) UNDER WHICH SONIDA WILL ACQUIRE 100% OF CHP IN A CASH AND STOCK TRANSACTION VALUED AT.
SNDA
• Nov. 5, 2025
MIRAMAR, FLA.--(BUSINESS WIRE)--VSE CORPORATION (“VSE” OR THE “COMPANY”) (NASDAQ: VSEC), A LEADING PROVIDER OF AVIATION AFTERMARKET DISTRIBUTION AND REPAIR SERVICES, ANNOUNCED TODAY THAT VSE CORPORATION'S SENIOR MANAGEMENT WILL PARTICIPATE IN THE FOLLOWING UPCOMING CONFERENCE. BAIRD 2025 GLOBAL INDUSTRIALS CONFERENCE WILL BE HELD IN CHICAGO, IL, ON NOVEMBER 11, 2025. JOHN CUOMO, PRESIDENT AND CHIEF EXECUTIVE OFFICER OF VSE CORPORATION, IS SCHEDULED TO PRESENT AT 9:05 AM CENTRAL TIME. MANAGEMENT.
VSEC
• Nov. 5, 2025
MILPITAS, CALIF. & MUNICH--(BUSINESS WIRE)--SOLAREDGE AND INFINEON ANNOUNCED A COLLABORATION TO ADVANCE SOLAREDGE'S SOLID-STATE TRANSFORMER (SST) PLATFORM FOR AI AND HYPERSCALE DATA CENTERS.
SEDG
• Nov. 5, 2025
LEXINGTON, KY.--(BUSINESS WIRE)--VALVOLINE INC. (NYSE: VVV), THE QUICK, EASY, TRUSTED LEADER IN PREVENTIVE AUTOMOTIVE MAINTENANCE, HAS ONCE AGAIN BEEN RECOGNIZED BY FORBES ON ITS ANNUAL LIST OF AMERICA'S BEST CUSTOMER SERVICE COMPANIES, REINFORCING THE BRAND'S ONGOING COMMITMENT TO DELIVERING HIGH QUALITY CUSTOMER EXPERIENCES. THE COMPANY RANKED 21ST OVERALL OUT OF THE 300 COMPANIES MAKING THE LIST, AND SECOND WITHIN THE AUTO REPAIR AND MAINTENANCE CATEGORY. “AT VALVOLINE INSTANT OIL CHANGE, PR.
VVV
• Nov. 5, 2025
TORONTO--(BUSINESS WIRE)--CYBIN INC. (NYSE AMERICAN:CYBN) (CBOE CA:CYBN) (”CYBIN” OR THE “COMPANY”), A BREAKTHROUGH PHASE 3 CLINICAL STAGE NEUROPSYCHIATRY COMPANY COMMITTED TO REVOLUTIONIZING MENTAL HEALTHCARE THROUGH PROPRIETARY DRUG DISCOVERY PLATFORMS AND INNOVATIVE DELIVERY SYSTEMS, TODAY ANNOUNCED THAT GEORGE TZIRAS, CYBIN'S CHIEF BUSINESS OFFICER, WILL PARTICIPATE IN A FIRESIDE CHAT AT THE GUGGENHEIM 2ND ANNUAL HEALTHCARE INNOVATION CONFERENCE, TAKING PLACE NOVEMBER 10-12, 2025, IN BOSTON.
CYBN
• Nov. 5, 2025
LAVAL, QUEBEC--(BUSINESS WIRE)--CRESCITA THERAPEUTICS INC. (TSX: CTX AND OTC US: CRRTF) (“CRESCITA” OR THE “COMPANY”), A GROWTH-ORIENTED, INNOVATION-DRIVEN CANADIAN COMMERCIAL DERMATOLOGY COMPANY, TODAY REPORTED ITS FINANCIAL RESULTS FOR THE THIRD QUARTER ENDED SEPTEMBER 30, 2025 (“Q3-2025”). ALL AMOUNTS PRESENTED ARE IN THOUSANDS OF CANADIAN DOLLARS (“CAD”) UNLESS OTHERWISE NOTED AND IN ACCORDANCE WITH INTERNATIONAL FINANCIAL REPORTING STANDARDS (“IFRS”) AS ISSUED BY THE INTERNATIONAL ACCOUNTI.
CRRTF
• Nov. 5, 2025
GOLETA, CALIF.--(BUSINESS WIRE)---- $INGN #AIRWAYCLEARANCE--INOGEN ANNOUNCES THIRD QUARTER 2025 FINANCIAL RESULTS DELIVERED SEVENTH CONSECUTIVE QUARTER OF MID-SINGLE-DIGIT REVENUE GROWTH.
INGN
• Nov. 5, 2025
MEDIWOUND TO REPORT THIRD QUARTER 2025 FINANCIAL RESULTS CONFERENCE CALL AND WEBCAST SCHEDULED FOR THURSDAY, NOVEMBER 20 AT 8:30 A.M. EASTERN TIME YAVNE, ISRAEL, NOVEMBER 5, 2025 -- MEDIWOUND LTD.
MDWD
• Nov. 5, 2025
BASED ON A CONTINUING TREND OF DECREASED MORTALITY IN THE ONGOING PHASE 2/3 COMPANION-002 STUDY OF TOVECIMIG (DLL4 X VEGF-A BISPECIFIC ANTIBODY) IN PATIENTS WITH ADVANCED BILIARY TRACT CANCER (BTC), THE ANALYSES OF OVERALL SURVIVAL (OS) AND PROGRESSION-FREE SURVIVAL (PFS) ARE EXPECTED IN LATE Q1 2026. A NEW RESPONSE IN A THIRD INDICATION HAS BEEN OBSERVED IN THE FIFTH AND FINAL DOSING COHORT OF THE PHASE 1 DOSE-ESCALATION STUDY OF CTX-8371 (PD-1 X PD-L1 BISPECIFIC ANTIBODY); NO DOSE-LIMITING TOXICITIES HAVE BEEN OBSERVED AT ANY DOSE LEVEL AND FULL TOPLINE DATA ARE NOW EXPECTED TO BE PRESENTED AT A MEDICAL MEETING IN H1 2026.
CMPX
• Nov. 5, 2025
GAITHERSBURG, MD., NOV. 05, 2025 (GLOBE NEWSWIRE) -- ALTIMMUNE, INC. (NASDAQ: ALT), A LATE CLINICAL-STAGE BIOPHARMACEUTICAL COMPANY DEVELOPING NOVEL PEPTIDE-BASED THERAPEUTICS FOR LIVER AND CARDIOMETABOLIC DISEASES, TODAY ANNOUNCED THAT MEMBERS OF THE COMPANY'S MANAGEMENT TEAM WILL PARTICIPATE AND BE AVAILABLE FOR ONE-ON-ONE MEETINGS AT THE FOLLOWING INVESTOR CONFERENCES: STIFEL 2025 HEALTHCARE CONFERENCE WEDNESDAY, NOVEMBER 12, 2025 FIRESIDE CHAT AT 10:00 A.M.
ALT
• Nov. 5, 2025
BURLINGTON, MASS., NOV. 05, 2025 (GLOBE NEWSWIRE) -- MINERVA NEUROSCIENCES, INC. (NASDAQ: NERV), A CLINICAL-STAGE BIOPHARMACEUTICAL COMPANY FOCUSED ON THE DEVELOPMENT OF THERAPIES TO TREAT CENTRAL NERVOUS SYSTEM (CNS) DISORDERS, TODAY REPORTED BUSINESS UPDATES AND FINANCIAL RESULTS FOR THE THIRD QUARTER OF 2025 ENDING SEPTEMBER 30, 2025.
NERV
• Nov. 5, 2025
ATHENS, GREECE AND NEW YORK, NOV. 05, 2025 (GLOBE NEWSWIRE) -- HEIDMAR MARITIME HOLDINGS CORP. (THE "COMPANY" OR "HEIDMAR") (NASDAQ: HMR) CONTINUES TO STRENGTHEN ITS MARKET POSITION BY ADDING SUPER-ECO VESSELS TO ITS MANAGED FLEET UNDER COMMERCIAL AND TECHNICAL MANAGEMENT AGREEMENTS.
HMR
• Nov. 5, 2025
TRANSACTION SIGNIFICANTLY REDUCES CORPORATE DEBT, INCREASES FINANCIAL FLEXIBILITY, AND STRENGTHENS BALANCE SHEET TRANSACTION SIGNIFICANTLY REDUCES CORPORATE DEBT, INCREASES FINANCIAL FLEXIBILITY, AND STRENGTHENS BALANCE SHEET
DFLI
• Nov. 5, 2025
WALTHAM, MASS., NOV. 05, 2025 (GLOBE NEWSWIRE) -- CRESCENT BIOPHARMA, INC. (“CRESCENT” OR THE “COMPANY”) (NASDAQ: CBIO), A BIOTECHNOLOGY COMPANY DEDICATED TO RAPIDLY ADVANCING THE NEXT WAVE OF THERAPIES FOR CANCER PATIENTS, TODAY ANNOUNCED THAT MANAGEMENT IS SCHEDULED TO PRESENT AT THE FOLLOWING INVESTOR CONFERENCES IN NOVEMBER:
CBIO
• Nov. 5, 2025
HOUSTON, NOV. 05, 2025 (GLOBE NEWSWIRE) -- PLAINS ALL AMERICAN PIPELINE, L.P. (NASDAQ: PAA) AND PLAINS GP HOLDINGS (NASDAQ: PAGP) TODAY REPORTED THIRD-QUARTER 2025 RESULTS AND PROVIDED THE FOLLOWING HIGHLIGHTS AND RECENT DEVELOPMENTS:
PAA
• Nov. 5, 2025
REDWOOD CITY, CALIF., NOV. 05, 2025 (GLOBE NEWSWIRE) -- REZOLUTE, INC. (NASDAQ: RZLT) (“REZOLUTE” OR THE “COMPANY”), A LATE-STAGE RARE DISEASE COMPANY FOCUSED ON TREATING HYPOGLYCEMIA CAUSED BY HYPERINSULINISM, TODAY ANNOUNCED THAT THE COMPANY WILL HOST A VIRTUAL INVESTOR EVENT VIA WEBCAST ON MONDAY, NOVEMBER 10, 2025, FROM 12:00 – 1:30 PM EST.
RZLT
• Nov. 5, 2025
HERZLIYA, ISRAEL, NOV. 05, 2025 (GLOBE NEWSWIRE) -- NAYAX LTD. (NASDAQ: NYAX; TASE: NYAX), A GLOBAL COMMERCE ENABLEMENT, PAYMENTS, AND LOYALTY PLATFORM HELPING MERCHANTS SCALE THEIR BUSINESS, TODAY ANNOUNCED THAT IT IS HOSTING NAYAX CONNECT LATAM WITH ITS PARTNER INTEGRAL VENDING TODAY FOR ITS CUSTOMERS IN THE REGION. THE EVENT WILL BE HOSTED AT THE LIVE AQUA IN MEXICO CITY. IN THE CONFERENCE, NAYAX WILL ANNOUNCE ITS EXPANSION PLANS FOR THE REGION AND THAT, AS PART OF THE EXPANSION EFFORTS, NAYAX HAS SIGNED A NON-BINDING LETTER OF INTENT AND ENTERED INTO EXCLUSIVITY TO ACQUIRE INTEGRAL VENDING, ITS EXCLUSIVE DISTRIBUTION PARTNER IN MEXICO SINCE 2015. THE TRANSACTION, IF COMPLETED, WILL TRANSFORM A DECADE-LONG PARTNERSHIP INTO A STRATEGIC PLATFORM FOR CONTINUED EXPANSION ACROSS LATIN AMERICA AND POSITION NAYAX TO CAPTURE ACCELERATING REGIONAL DEMAND FOR ITS CASHLESS PAYMENT, SOFTWARE, AND LOYALTY PLATFORM.
NYAX
• Nov. 5, 2025
LOUISVILLE, KY., NOV. 05, 2025 (GLOBE NEWSWIRE) -- CREATIVE REALITIES, INC. (“CREATIVE REALITIES,” “CRI,” OR THE “COMPANY”) (NASDAQ: CREX), A LEADING PROVIDER OF DIGITAL SIGNAGE AND MEDIA SOLUTIONS, TODAY ANNOUNCED THAT IT WILL PARTICIPATE IN THE 16TH ANNUAL CRAIG-HALLUM ALPHA SELECT CONFERENCE AT THE SHERATON NY TIMES SQUARE HOTEL ON TUESDAY, NOVEMBER 18. THE DAY WILL CONSIST OF ONE-ON-ONE MEETINGS WITH MANAGEMENT, AND INSTITUTIONAL INVESTORS CAN CONTACT CRAIG-HALLUM DIRECTLY TO SET UP TIME WITH THE COMPANY.
CREX
• Nov. 5, 2025
HOUSTON, NOV. 05, 2025 (GLOBE NEWSWIRE) -- MARKER THERAPEUTICS, INC. (NASDAQ: MRKR), A CLINICAL-STAGE IMMUNO-ONCOLOGY COMPANY FOCUSING ON DEVELOPING NEXT-GENERATION T CELL-BASED IMMUNOTHERAPIES FOR THE TREATMENT OF HEMATOLOGICAL MALIGNANCIES AND SOLID TUMOR INDICATIONS, TODAY ANNOUNCED THE APPOINTMENT OF KATHRYN PENKUS CORZO, R.PH., MBA TO THE COMPANY'S BOARD OF DIRECTORS, EFFECTIVE NOVEMBER 1, 2025.
MRKR
• Nov. 5, 2025
MISSISSAUGA, ONTARIO--(NEWSFILE CORP. - NOVEMBER 5, 2025) - VIQ SOLUTIONS INC. (TSXV: VQS) ("VIQ", "VIQ SOLUTIONS" OR THE "COMPANY"), A GLOBAL PROVIDER OF SECURE, AI-DRIVEN, DIGITAL VOICE AND VIDEO CAPTURE TECHNOLOGY AND TRANSCRIPTION SERVICES, IS PLEASED TO ANNOUNCE IT HAS CLOSED THE SECOND TRANCHE OF ITS UPSIZED NON-BROKERED PRIVATE PLACEMENT OF UNITS OF THE COMPANY ("UNITS") FOR ADDITIONAL GROSS PROCEEDS OF APPROXIMATELY C$585,000 (THE "OFFERING"). AS PART OF THE SECOND TRANCHE OF THE OFFERING, THE COMPANY ISSUED AN ADDITIONAL 3,146,063 UNITS AT A PRICE PER UNIT OF C$0.186.
VQSSF
• Nov. 5, 2025
TORONTO, ONTARIO--(NEWSFILE CORP. - NOVEMBER 5, 2025) - MINNOVA CORP. (TSXV: MCI) ("MINNOVA" OR THE "COMPANY") IS PLEASED TO ANNOUNCE THAT IT HAS ENTERED INTO AN AGREEMENT WITH RED CLOUD SECURITIES INC. ("RED CLOUD") TO ACT AS SOLE AGENT AND BOOKRUNNER IN CONNECTION WITH A "BEST EFFORTS" PRIVATE PLACEMENT (THE "MARKETED OFFERING") FOR AGGREGATE GROSS PROCEEDS OF UP TO C$5,000,000 FROM THE SALE OF ANY COMBINATION OF THE FOLLOWING: UNITS OF THE COMPANY (EACH, A "UNIT") AT A PRICE OF C$0.20 PER UNIT (THE "UNIT PRICE"), SUBJECT TO THE MINIMUM SALE OF 10,000,000 UNITS FOR MINIMUM GROSS PROCEEDS OF C$2,000,000 FROM THE SALE OF UNITS; FLOW-THROUGH UNITS OF THE COMPANY (EACH, A "FT UNIT") AT A PRICE OF C$0.23 PER FT UNIT; AND FLOW-THROUGH UNITS OF THE COMPANY TO BE SOLD TO CHARITABLE PURCHASERS (EACH, A "CHARITY FT UNIT", AND COLLECTIVELY WITH THE UNITS AND FT UNITS, THE "OFFERED SECURITIES") AT A PRICE OF C$0.32 PER CHARITY FT UNIT. EACH UNIT WILL CONSIST OF ONE COMMON SHARE OF THE COMPANY (A "UNIT SHARE") AND ONE COMMON SHARE PURCHASE WARRANT (EACH, A "WARRANT").
AGRDF
• Nov. 5, 2025
JLL ACHIEVED SIXTH CONSECUTIVE QUARTER OF DOUBLE-DIGIT REVENUE GROWTH AND DELIVERED A 45% INCREASE IN DILUTED EARNINGS PER SHARE CHICAGO , NOV. 5, 2025 /PRNEWSWIRE/ -- JONES LANG LASALLE INCORPORATED (NYSE: JLL) TODAY REPORTED OPERATING PERFORMANCE FOR THE THIRD QUARTER OF 2025 WITH DILUTED EARNINGS PER SHARE OF $4.61 (UP 45%) AND ADJUSTED DILUTED EARNINGS PER SHARE1 OF $4.50 (UP 29%). TRANSACTIONAL4 REVENUES RETURNED TO DOUBLE-DIGIT GROWTH THIS QUARTER AND RESILIENT4 REVENUES EXTENDED ITS GROWTH STREAK WITH TOP-LINE INCREASES EVERY QUARTER STRETCHING BACK TO THE REORGANIZATION OF THE COMPANY'S SEGMENTS IN Q1 2022.
JLL
• Nov. 5, 2025
RECORD QUARTERLY REVENUE DEMONSTRATES STRENGTH AND RESILIENCE OF DIVERSE BUSINESS MODEL INCREASING 2025 GUIDANCE NEW YORK , NOV. 5, 2025 /PRNEWSWIRE/ -- PAYONEER GLOBAL INC. ("PAYONEER" OR THE "COMPANY") (NASDAQ: PAYO), THE GLOBAL FINANCIAL TECHNOLOGY COMPANY POWERING BUSINESS GROWTH ACROSS BORDERS, TODAY REPORTED FINANCIAL RESULTS FOR ITS THIRD QUARTER ENDED SEPTEMBER 30, 2025. THIRD QUARTER 2025 FINANCIAL HIGHLIGHTS YOY ($ IN MM) 3Q 2024 4Q 2024 1Q 2025 2Q 2025 3Q 2025 CHANGE REVENUE EX.
PAYO
• Nov. 5, 2025
ANNOUNCES 2025 THIRD-QUARTER REPORTED EARNINGS (GAAP) PER SHARE OF $0.43. ACHIEVES 2025 THIRD-QUARTER ONGOING EARNINGS PER SHARE OF $0.48 VERSUS $0.42 IN 2024.
PPL
• Nov. 5, 2025
WEST CHESTER, PA. , NOV. 5, 2025 /PRNEWSWIRE/ -- QVC GROUP, INC. ("QVC GROUP") (NASDAQ: QVCGA, QVCGP; OTCQB: QVCGB) TODAY REPORTED THIRD QUARTER 2025 RESULTS(1).
QVCGP
• Nov. 5, 2025
NEW YORK , NOV. 5, 2025 /PRNEWSWIRE/ -- SHUTTERSTOCK, INC. (NYSE: SSTK) (THE "COMPANY"), A FAMILY OF BRANDS DELIVERING SCALABLE CREATIVE AND GENAI SOLUTIONS TO HELP CUSTOMERS FUEL GREAT WORK, TODAY ANNOUNCED FINANCIAL RESULTS FOR THE THIRD QUARTER ENDED SEPTEMBER 30, 2025. COMMENTING ON THE COMPANY'S PERFORMANCE, PAUL HENNESSY, THE COMPANY'S CHIEF EXECUTIVE OFFICER, SAID, "SHUTTERSTOCK ACHIEVED ANOTHER STRONG QUARTER OF FINANCIAL RESULTS.
SSTK
• Nov. 5, 2025
ORIGIN 3 TRIAL PRIMARY ENDPOINT RESULTS FOR ATACICEPT IN IGA NEPHROPATHY (IGAN) SELECTED AS A FEATURED LATE-BREAKING ORAL PRESENTATION DURING OPENING PLENARY SESSION OF AMERICAN SOCIETY OF NEPHROLOGY (ASN) KIDNEY WEEK 2025 BIOLOGICS LICENSE APPLICATION (BLA) SUBMISSION THROUGH THE ACCELERATED APPROVAL PROGRAM FOR ATACICEPT FOR THE TREATMENT OF IGAN TO U.S. FDA EXPECTED IN Q4; POTENTIAL U.S. COMMERCIAL LAUNCH OF ATACICEPT IN 2026 ACTIVELY ENROLLING PATIENTS IN THE PIONEER, ATACICEPT MONTHLY DOSE RANGE FINDING, AND ORIGIN EXTEND STUDIES BRISBANE, CALIF., NOV. 05, 2025 (GLOBE NEWSWIRE) -- VERA THERAPEUTICS, INC. (NASDAQ: VERA), A LATE CLINICAL-STAGE BIOTECHNOLOGY COMPANY FOCUSED ON DEVELOPING AND COMMERCIALIZING TRANSFORMATIVE TREATMENTS FOR PATIENTS WITH SERIOUS IMMUNOLOGICAL DISEASES, TODAY REPORTED ITS BUSINESS HIGHLIGHTS AND FINANCIAL RESULTS FOR THE THIRD QUARTER ENDED SEPTEMBER 30, 2025.
VERA
• Nov. 5, 2025
LYNCHBURG, VA.--(BUSINESS WIRE)--BWX TECHNOLOGIES, INC. (NYSE: BWXT) (“BWXT”) ANNOUNCED TODAY THAT IT INTENDS TO OFFER, SUBJECT TO MARKET AND OTHER CONDITIONS, $1.0 BILLION AGGREGATE PRINCIPAL AMOUNT OF CONVERTIBLE SENIOR NOTES DUE 2030 (THE “NOTES”), TO BE SOLD ONLY TO PERSONS REASONABLY BELIEVED TO BE QUALIFIED INSTITUTIONAL BUYERS PURSUANT TO RULE 144A UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”). BWXT ALSO EXPECTS TO GRANT TO THE INITIAL PURCHASERS OF THE NOTES AN OPT.
BWXT
• Nov. 5, 2025
CHICAGO--(BUSINESS WIRE)--ALIGHT, INC. (THE “COMPANY” OR “ALIGHT”) (NYSE: ALIT), A LEADING CLOUD-BASED HUMAN CAPITAL AND TECHNOLOGY-ENABLED SERVICES PROVIDER, ANNOUNCED THAT ITS BOARD OF DIRECTORS HAS APPROVED DECLASSIFYING THE BOARD AND INTENDS TO ASK STOCKHOLDERS TO VOTE ON A PROPOSAL TO APPROVE AMENDMENTS TO THE COMPANY'S CERTIFICATE OF INCORPORATION TO EFFECTUATE THE PHASED DECLASSIFICATION OF THE BOARD (THE “DECLASSIFICATION PROPOSAL”) AT THE 2026 ANNUAL MEETING OF STOCKHOLDERS (THE “2026.
ALIT
• Nov. 5, 2025
MEMPHIS, TENN.--(BUSINESS WIRE)--FRONTDOOR, INC. (NASDAQ: FTDR), THE NATION'S LEADING PROVIDER OF HOME WARRANTIES, ANNOUNCED TODAY THAT ITS BOARD OF DIRECTORS HAS APPOINTED JASON BAILEY AS SENIOR VICE PRESIDENT AND CHIEF FINANCIAL OFFICER. BAILEY SUCCEEDS JESSICA ROSS, WHO RESIGNED AS CFO EFFECTIVE NOVEMBER 10, 2025. ROSS WILL REMAIN WITH THE COMPANY THROUGH DECEMBER 31, 2025 AS AN ADVISOR TO THE CEO TO ENSURE A SMOOTH TRANSITION OF HER RESPONSIBILITIES. “JESSICA HAS MADE MANY CONTRIBUTIONS TO.
FTDR
• Nov. 5, 2025
ROSH-HA`AYIN, ISRAEL, NOV. 05, 2025 (GLOBE NEWSWIRE) -- KORNIT DIGITAL LTD. (“KORNIT” OR THE “COMPANY”) (NASDAQ: KRNT), A GLOBAL LEADER IN SUSTAINABLE, ON-DEMAND DIGITAL FASHION AND TEXTILE PRODUCTION, TODAY ANNOUNCED FINANCIAL RESULTS FOR THE THIRD QUARTER ENDED SEPTEMBER 30, 2025. THE RESULTS REFLECT KORNIT'S CONSISTENT EXECUTION OF ITS STRATEGY TO ACCELERATE DIGITAL ADOPTION IN MASS APPAREL PRODUCTION, EXPAND RECURRING REVENUES UNDER THE ALL-INCLUSIVE CLICK (AIC) MODEL, AND STRENGTHEN ITS LEADERSHIP IN REPLACING TRADITIONAL SCREEN PRINTING WITH AGILE, ON-DEMAND DIGITAL SOLUTIONS.
KRNT
• Nov. 5, 2025
MALVERN, PA., NOV. 05, 2025 (GLOBE NEWSWIRE) -- VISHAY INTERTECHNOLOGY, INC., (NYSE: VSH), ONE OF THE WORLD'S LARGEST MANUFACTURERS OF DISCRETE SEMICONDUCTORS AND PASSIVE ELECTRONIC COMPONENTS, TODAY ANNOUNCED RESULTS FOR THE FISCAL THIRD QUARTER ENDED SEPTEMBER 27, 2025.
VSH
• Nov. 5, 2025
AUTONOMOUS SYSTEMS, ADVANCED MACHINERY, TALKING TRACTOR CONCEPT AND MIXED-FLEET MANAGEMENT PLATFORM TAKE CENTER STAGE HANOVER, GERMANY , NOV. 5, 2025 /PRNEWSWIRE/ -- AGCO (NYSE: AGCO), A GLOBAL LEADER IN THE DESIGN, MANUFACTURE AND DISTRIBUTION OF AGRICULTURAL MACHINERY AND PRECISION AG TECHNOLOGY, WILL RETURN TO AGRITECHNICA 2025 TO SHOWCASE ITS ICONIC MACHINE AND TECHNOLOGY BRANDS – FENDT®, MASSEY FERGUSON®, PTX® AND VALTRA® – AT THE WORLD'S LARGEST INDOOR AGRICULTURAL TRADE FAIR. HUNDREDS OF THOUSANDS OF FARMERS AND DEALERS WILL EXPERIENCE THE LATEST PRODUCT LAUNCHES AND INNOVATIVE TECHNOLOGIES FROM AGCO'S LEADING BRANDS ALONGSIDE OFFERINGS FROM AGCO POWER™ AND AGCO FINANCE®.
AGCO
• Nov. 5, 2025
ZUG, SWITZERLAND, NOVEMBER 5, 2025 – MOONLAKE IMMUNOTHERAPEUTICS (NASDAQ: MLTX) (“MOONLAKE”), A CLINICAL-STAGE BIOTECHNOLOGY COMPANY FOCUSED ON ADVANCING THERAPIES TO ADDRESS SIGNIFICANT UNMET NEEDS IN INFLAMMATORY SKIN AND JOINT DISEASES, TODAY ANNOUNCED THE PRICING OF AN UNDERWRITTEN OFFERING OF 7,142,857 CLASS A ORDINARY SHARES AT AN OFFERING PRICE PER SHARE OF $10.50. THE GROSS PROCEEDS FROM THE OFFERING TO MOONLAKE, BEFORE DEDUCTING THE UNDERWRITING DISCOUNTS AND COMMISSIONS AND OTHER OFFERING EXPENSES PAYABLE BY MOONLAKE, ARE EXPECTED TO BE APPROXIMATELY $75 MILLION.
MLTX
• Nov. 5, 2025
BROOMFIELD, COLO.--(BUSINESS WIRE)--DIGITALOCEAN HOLDINGS, INC. (NYSE: DOCN), THE COMPREHENSIVE AGENTIC CLOUD, TODAY ANNOUNCED RESULTS FOR ITS THIRD QUARTER ENDED SEPTEMBER 30, 2025. “DIGITALOCEAN'S UNIFIED AGENTIC CLOUD IS DRIVING ACCELERATED MOMENTUM IN Q3. REVENUE INCREASED 16% YEAR OVER YEAR AND WE DELIVERED THE STRONGEST INCREMENTAL ORGANIC ARR IN OUR HISTORY,” SAID PADDY SRINIVASAN, CEO OF DIGITALOCEAN. “OUR UNIFIED AGENTIC CLOUD PLATFORM IS EMERGING AS A PREFERRED DESTINATION FOR AI AND.
DOCN
• Nov. 5, 2025
MINNEAPOLIS, NOV. 05, 2025 (GLOBE NEWSWIRE) -- CELCUITY INC. (NASDAQ: CELC), A CLINICAL-STAGE BIOTECHNOLOGY COMPANY PURSUING DEVELOPMENT OF TARGETED THERAPIES FOR ONCOLOGY, TODAY ANNOUNCED THAT IT WILL RELEASE ITS FINANCIAL RESULTS FOR THE THIRD QUARTER 2025 AFTER THE MARKET CLOSES ON WEDNESDAY, NOVEMBER 12, 2025. MANAGEMENT WILL HOST A WEBCAST/TELECONFERENCE THE SAME DAY AT 4:30 P.M.
CELC
• Nov. 5, 2025
COMMERCIAL CHANNEL REVENUE UP 22% WITH CONTINUED STRONG INTEGRITY ™ IMPLANT SYSTEM AND HYALOFAST® GROWTH, AND DOUBLE-DIGIT INTERNATIONAL OA PAIN MANAGEMENT GROWTH THIRD AND FINAL HYALOFAST PMA MODULE FILED AND DATA RELEASED CINGAL® ACHIEVED COMMERCIAL MILESTONE OF MORE THAN ONE MILLION INJECTIONS WORLDWIDE SINCE 2016 REAFFIRMING FISCAL 2025 GUIDANCE AND LONG-TERM OUTLOOK AND COMMENCING A $15 MILLION 10B5-1 SHARE REPURCHASE BEDFORD, MASS., NOV. 05, 2025 (GLOBE NEWSWIRE) -- ANIKA THERAPEUTICS, INC. (NASDAQ: ANIK), A GLOBAL LEADER IN THE OSTEOARTHRITIS (“OA”) PAIN MANAGEMENT AND REGENERATIVE SOLUTIONS SPACES FOCUSED ON EARLY INTERVENTION ORTHOPEDICS, TODAY ANNOUNCED FINANCIAL RESULTS FOR THE THIRD QUARTER ENDED SEPTEMBER 30, 2025.
ANIK
• Nov. 5, 2025
SAN DIEGO, NOV. 05, 2025 (GLOBE NEWSWIRE) -- SKYE BIOSCIENCE, INC. (NASDAQ: SKYE) (“SKYE”), A CLINICAL-STAGE BIOTECHNOLOGY COMPANY FOCUSED ON UNLOCKING NEW THERAPEUTIC PATHWAYS FOR OBESITY AND OTHER METABOLIC HEALTH DISORDERS, TODAY ANNOUNCED THAT IT WILL PRESENT A LATE-BREAKING ORAL PRESENTATION AT OBESITYWEEK 2025 ON NOVEMBER 7, 2025, IN ATLANTA, GEORGIA. THE PRESENTATION WILL HIGHLIGHT RECENT TOPLINE DATA FROM CBEYOND™, A PHASE 2 PROOF-OF-CONCEPT STUDY OF NIMACIMAB, SKYE'S PERIPHERALLY-RESTRICTED CB1 INHIBITOR ANTIBODY.
SKYE
• Nov. 5, 2025
FUTURE RELOCATION AND EXPANSION TO CREATE UP TO 100 NEW JOBS OVER 5 YEARS CITY APPROVES UP TO $300,000 IN ECONOMIC INCENTIVES TO RAPIDLY GROWING MEDTECH BUSINESS POMPANO BEACH, FLA., NOV. 5, 2025 – PRISM MEDIAWIRE (PRESS RELEASE SERVICE – PRESS RELEASE DISTRIBUTION) – BIOSTEM TECHNOLOGIES, INC.
BSEM
• Nov. 5, 2025
LEXINGTON, KY. , NOV. 5, 2025 /PRNEWSWIRE/ -- RAMACO RESOURCES, INC. (NASDAQ: METC) ("RAMACO") TODAY ANNOUNCED THE PRICING OF ITS PUBLIC OFFERING OF $300,000,000 AGGREGATE PRINCIPAL AMOUNT OF 0% CONVERTIBLE SENIOR NOTES DUE 2031 (THE "NOTES").
METC
• Nov. 5, 2025
LEXINGTON, KY. , NOV. 5, 2025 /PRNEWSWIRE/ -- RAMACO RESOURCES, INC. (NASDAQ: METC) ("RAMACO" OR THE "COMPANY") ANNOUNCED TODAY, IN A SEPARATE PRESS RELEASE, THE PRICING OF ITS PREVIOUSLY ANNOUNCED UNDERWRITTEN PUBLIC OFFERING OF $300,000,000 AGGREGATE PRINCIPAL AMOUNT OF 0% CONVERTIBLE SENIOR NOTES DUE 2031 (THE "NOTES"), FOR TOTAL NET PROCEEDS OF APPROXIMATELY $290.9 MILLION, PLUS UP TO AN ADDITIONAL $45,000,000 AGGREGATE PRINCIPAL AMOUNT OF NOTES THAT THE UNDERWRITERS OF THE NOTES OFFERING HAVE THE OPTION TO PURCHASE FROM RAMACO SOLELY TO COVER OVER-ALLOTMENTS.
METC
• Nov. 5, 2025
NEW YORK--(BUSINESS WIRE)--THE NEW YORK TIMES COMPANY (NYSE: NYT) ANNOUNCED TODAY THAT ITS THIRD-QUARTER 2025 FINANCIAL RESULTS ARE AVAILABLE ON THE NEW YORK TIMES COMPANY'S INVESTOR RELATIONS WEBSITE AT INVESTORS.NYTCO.COM. AS PREVIOUSLY ANNOUNCED, THE NEW YORK TIMES COMPANY WILL HOST ITS EARNINGS CONFERENCE CALL TODAY AT 8:00 A.M. E.T. TO DISCUSS THESE RESULTS. A LIVE WEBCAST OF THE EARNINGS CONFERENCE CALL WILL BE AVAILABLE AT INVESTORS.NYTCO.COM. PARTICIPANTS CAN PRE-REGISTER FOR THE TELEPH.
NYT
• Nov. 5, 2025
WILMINGTON, MASS.--(BUSINESS WIRE)--CHARLES RIVER LABORATORIES PROVIDES UPDATE ON STRATEGIC REVIEW.
CRL
• Nov. 5, 2025
NEW YORK--(BUSINESS WIRE)--MIND MEDICINE (MINDMED) INC. (NASDAQ: MNMD) (THE “COMPANY” OR “MINDMED”), A LATE-STAGE CLINICAL BIOPHARMACEUTICAL COMPANY DEVELOPING NOVEL PRODUCT CANDIDATES TO TREAT BRAIN HEALTH DISORDERS, TODAY ANNOUNCED THAT MEMBERS OF THE COMPANY'S MANAGEMENT TEAM WILL PARTICIPATE IN THE FOLLOWING INVESTOR CONFERENCES: STIFEL 2025 HEALTHCARE CONFERENCE FORMAT: PRESENTATION DATE AND TIME: WEDNESDAY, NOVEMBER 12, 2025 AT 1:20 PM ET LOCATION: NEW YORK, NY WEBCAST LINK: STIFEL 2025 H.
MNMD
• Nov. 5, 2025
WALTHAM, MASS.--(BUSINESS WIRE)--VIRIDIAN THERAPEUTICS, INC. (NASDAQ: VRDN), A BIOTECHNOLOGY COMPANY FOCUSED ON DISCOVERING, DEVELOPING, AND COMMERCIALIZING POTENTIALLY BEST-IN-CLASS MEDICINES FOR SERIOUS AND RARE DISEASES, TODAY REPORTED RECENT BUSINESS HIGHLIGHTS AND FINANCIAL RESULTS FOR THE THIRD QUARTER ENDED SEPTEMBER 30, 2025. “THE VIRIDIAN TEAM CONTINUES TO DELIVER STRONG RESULTS, HIGHLIGHTED BY THE SUCCESSFUL SUBMISSION OF OUR BLA FOR VELIGROTUG, COMPLETING ENROLLMENT IN BOTH PIVOTAL C.
VRDN
• Nov. 5, 2025
BERKELEY HEIGHTS, N.J., NOV. 05, 2025 (GLOBE NEWSWIRE) -- SECURA BIO, INC. (WWW.SECURABIO.COM), AN INTEGRATED PHARMACEUTICAL COMPANY MAXIMIZING COMMERCIAL OUTCOMES FOR ONCOLOGY MEDICINES, TODAY ANNOUNCED THAT CHIP ROMP, CHIEF EXECUTIVE OFFICER, AND WILL BROWN, CHIEF FINANCIAL OFFICER WILL PARTICIPATE IN UPCOMING JEFFERIES GLOBAL HEALTHCARE CONFERENCE TAKING PLACE FROM NOVEMBER 17 TO 20, 2025 IN LONDON, UK.
JEF
• Nov. 5, 2025
RESEARCH TRIANGLE PARK, N.C., NOV. 05, 2025 (GLOBE NEWSWIRE) -- BIOCRYST PHARMACEUTICALS, INC. (NASDAQ: BCRX) TODAY ANNOUNCED THAT THE COMPENSATION COMMITTEE OF BIOCRYST'S BOARD OF DIRECTORS GRANTED THREE NEWLY-HIRED EMPLOYEES RESTRICTED STOCK UNITS (RSUS) COVERING AN AGGREGATE OF 30,700 SHARES OF BIOCRYST COMMON STOCK. THE RSUS WERE GRANTED AS OF NOVEMBER 3, 2025, AS INDUCEMENTS MATERIAL TO EACH EMPLOYEE ENTERING INTO EMPLOYMENT WITH BIOCRYST. THE RSUS WERE GRANTED IN ACCORDANCE WITH NASDAQ LISTING RULE 5635(C)(4).
BCRX
• Nov. 5, 2025
THIRD QUARTER 2025 OVERVIEW (ALL COMPARISONS ARE MADE TO THE CORRESPONDING PRIOR YEAR THIRD QUARTER UNLESS OTHERWISE SPECIFIED):
ASTE
• Nov. 5, 2025
ORDERS RECEIVED FOR SEVENTH AND EIGHT TURNKEY PROJECTS WITH THIS CUSTOMER OTTAWA, ONTARIO--(NEWSFILE CORP. - NOVEMBER 5, 2025) - THERMAL ENERGY INTERNATIONAL INC. (TSXV: TMG) (OTCQB: TMGEF) ("THERMAL ENERGY " OR THE "COMPANY"), A PROVIDER OF INNOVATIVE ENERGY EFFICIENCY AND CARBON EMISSION REDUCTION SOLUTIONS TO MAJOR CORPORATIONS AROUND THE WORLD, HAS RECEIVED ORDERS FOR TWO TURNKEY HEAT RECOVERY PROJECTS WORTH A COMBINED TOTAL OF $1.5 MILLION FROM A GLOBAL NUTRITION COMPANY. ALL FIGURES ARE SHOWN IN CAD.
GTLL
• Nov. 5, 2025
NORTH CANTON, OHIO , NOV. 5, 2025 /PRNEWSWIRE/ -- DIEBOLD NIXDORF (NYSE: DBD), A GLOBAL LEADER IN TRANSFORMING THE WAY PEOPLE BANK AND SHOP, TODAY ANNOUNCED THAT ITS BOARD OF DIRECTORS HAS AUTHORIZED A NEW SHARE REPURCHASE PROGRAM WHEREBY THE COMPANY MAY REPURCHASE UP TO $200 MILLION SHARES OF ITS COMMON STOCK. THE PREVIOUS $100 MILLION SHARE REPURCHASE PROGRAM, ANNOUNCED ON FEB. 12, 2025, IS NOW COMPLETE.
DBD
• Nov. 5, 2025
THIRD CONSECUTIVE QUARTER OF DOUBLE-DIGIT YOY ORDER ENTRY GROWTH, WITH SOLID OPERATIONAL PERFORMANCE IN BANKING AND STRONG DEMAND MOMENTUM IN RETAIL FREE CASH FLOW APPROXIMATELY DOUBLING SEQUENTIALLY BOARD AUTHORIZES NEW $200 MILLION SHARE REPURCHASE AUTHORIZATION; INITIAL $100 MILLION SHARE REPURCHASE PROGRAM ANNOUNCED FEB. 12, 2025 IS NOW COMPLETE COMPANY REAFFIRMS 2025 OUTLOOK WITH CLEAR LINE OF SIGHT TO STRONG Q4 MATERIALS AND INVESTOR CALL INFORMATION AVAILABLE AT HTTP://WWW.DIEBOLDNIXDORF.COM/EARNINGS NORTH CANTON, OHIO , NOV. 5, 2025 /PRNEWSWIRE/ -- DIEBOLD NIXDORF (NYSE: DBD), A WORLD LEADER IN TRANSFORMING THE WAY PEOPLE BANK AND SHOP, TODAY REPORTED ITS 2025 THIRD QUARTER FINANCIAL RESULTS. THE FULL PRESS RELEASE, A PRESENTATION SUMMARIZING RESULTS FROM THE PERIOD AND INVESTOR CALL INFORMATION ARE AVAILABLE AT THE INVESTOR RELATIONS SECTION OF DIEBOLD NIXDORF'S WEBSITE AT HTTP://WWW.DIEBOLDNIXDORF.COM/EARNINGS.
DBD
• Nov. 5, 2025
CRANBROOK, BC / ACCESS NEWSWIRE / NOVEMBER 5, 2025 / EAGLE PLAINS RESOURCES LTD. (TSXV:EPL)(OTCQB:EGPLF) ("EPL" OR "EAGLE PLAINS") HAS BEEN NOTIFIED BY OPTION PARTNER XCITE RESOURCES INC.(TSXV:XRI) ("XCITE"), THAT SURVEY EQUIPMENT HAS BEEN MOBILIZED TO COMMENCE A GEOPHYSICAL SURVEY ON EPL'S 100% OWNED BEAVER RIVER, BLACK BAY, DON LAKE, GULCH, LORADO AND SMITTY PROJECTS.
EGPLF
• Nov. 5, 2025
CENTENNIAL, CO / ACCESS NEWSWIRE / NOVEMBER 5, 2025 / NIOCORP DEVELOPMENTS LTD. ("NIOCORP" OR THE "COMPANY") (NASDAQ:NB), A LEADING U.S. CRITICAL MINERALS DEVELOPER, IS PLEASED TO REPORT ASSAY RESULTS FROM THE SECOND DIAMOND DRILL HOLE COMPLETED AS PART OF THE COMPANY'S DRILLING PROGRAM AT ITS CRITICAL MINERALS PROJECT IN SOUTHEAST NEBRASKA (THE "ELK CREEK PROJECT").
NB
• Nov. 5, 2025
MINNEAPOLIS--(BUSINESS WIRE)--SLEEP NUMBER CORPORATION (NASDAQ: SNBR) TODAY REPORTED RESULTS FOR THE QUARTER ENDED SEPTEMBER 27, 2025. LINDA FINDLEY, PRESIDENT AND CEO, COMMENTED, “WE HAVE SUCCESSFULLY EXECUTED AN AMENDMENT AND EXTENSION OF OUR BANK AGREEMENT THROUGH 2027, GIVING US GREATER FLEXIBILITY TO FURTHER OUR TURNAROUND PLANS. WITH THIS NEW AGREEMENT, COMBINED WITH MEANINGFUL FIXED COST REDUCTIONS ACHIEVED IN 2025, WE WILL INVEST IN GROWTH IN 2026. TO DRIVE CONSUMER DEMAND, WE ARE MAKIN.
SNBR
• Nov. 5, 2025
MISSION WOODS, KAN.--(BUSINESS WIRE)--PALMER SQUARE CAPITAL BDC INC. (NYSE: PSBD) (“PSBD” OR THE “COMPANY”), AN EXTERNALLY MANAGED BUSINESS DEVELOPMENT COMPANY, TODAY ANNOUNCED ITS FINANCIAL RESULTS FOR THE THIRD QUARTER ENDED SEPTEMBER 30, 2025. FINANCIAL AND OPERATING HIGHLIGHTS TOTAL INVESTMENT INCOME OF $31.7 MILLION FOR THE THIRD QUARTER OF 2025, COMPARED TO $37.3 MILLION FOR THE PRIOR YEAR PERIOD NET INVESTMENT INCOME OF $13.6 MILLION OR $0.43 PER SHARE FOR THE THIRD QUARTER OF 2025, AS C.
BDC
• Nov. 5, 2025
AUSTIN, TEXAS & LIVINGSTON, N.J.--(BUSINESS WIRE)--AT FAL.CON EUROPE 2025, CROWDSTRIKE (NASDAQ: CRWD) AND COREWEAVE, THE ESSENTIAL CLOUD FOR AI™, ANNOUNCED A MAJOR GLOBAL PARTNERSHIP TO POWER THE SECURE AI CLOUD FOUNDATION FOR THE AGENTIC ERA AND ACCELERATE THE MARCH TOWARD SECURE AGI. THE COLLABORATION COMBINES COREWEAVE'S HIGH-PERFORMANCE AI CLOUD WITH THE CROWDSTRIKE FALCON® PLATFORM'S INDUSTRY-LEADING PROTECTION TO SECURE AND ACCELERATE THE COMPLEX COMPUTING WORKLOADS THAT DRIVE MODERN AI I.
CRWD
• Nov. 5, 2025
HAMILTON, BERMUDA--(BUSINESS WIRE)--ASSURED GUARANTY LTD. (NYSE:AGO) TODAY DECLARED A QUARTERLY DIVIDEND OF $0.34 PER COMMON SHARE. THE DIVIDEND IS PAYABLE ON DECEMBER 3, 2025 TO SHAREHOLDERS OF RECORD AT THE CLOSE OF BUSINESS ON NOVEMBER 19, 2025. ASSURED GUARANTY LTD. IS A PUBLICLY TRADED (NYSE: AGO) BERMUDA-BASED HOLDING COMPANY. THROUGH ITS SUBSIDIARIES, ASSURED GUARANTY PROVIDES CREDIT ENHANCEMENT PRODUCTS TO THE U.S. AND INTERNATIONAL PUBLIC FINANCE, INFRASTRUCTURE AND STRUCTURED FINANCE.
AGO
• Nov. 5, 2025
CALGARY, ALBERTA--(BUSINESS WIRE)--PEMBINA PIPELINE CORPORATION ("PEMBINA") (TSX: PPL; NYSE: PBA) AND PETROLIAM NASIONAL BERHAD ("PETRONAS") TODAY ANNOUNCED THE SIGNING OF A 20-YEAR AGREEMENT (THE "AGREEMENT") FOR 1.0 MILLION TONNES PER ANNUM ("MTPA") OF PEMBINA'S LIQUEFACTION CAPACITY AT THE CEDAR LNG FACILITY ("CEDAR LNG") BY THEIR SUBSIDIARIES. THE AGREEMENT IS A SYNTHETIC LIQUEFACTION SERVICE STRUCTURE FOR 1.0 MTPA OF CAPACITY, UNDER WHICH PEMBINA WILL PROVIDE TRANSPORTATION AND LIQUEFACTIO.
LNG
• Nov. 5, 2025
MILPITAS, CALIF.--(BUSINESS WIRE)--SOLAREDGE TECHNOLOGIES, INC. (NASDAQ: SEDG), A GLOBAL LEADER IN SMART ENERGY TECHNOLOGY, TODAY ANNOUNCED ITS FINANCIAL RESULTS FOR THE THIRD QUARTER ENDED SEPTEMBER 30, 2025. “WE'RE MAKING STEADY PROGRESS IN OUR TURNAROUND, WITH THREE CONSECUTIVE QUARTERS OF REVENUE GROWTH AND IMPROVING MARGINS, AND WE'RE NOT DONE YET,” SAID SHUKI NIR, CEO OF SOLAREDGE. “WITH ENERGY TAKING AN INCREASINGLY VITAL ROLE IN POWERING THE GLOBAL ECONOMY, WE BELIEVE THAT SOLAREDGE IS.
SEDG
• Nov. 5, 2025
RICHMOND, VA.--(BUSINESS WIRE)--PERFORMANCE FOOD GROUP COMPANY REPORTS FIRST-QUARTER FISCAL 2026 RESULTS.
PFGC
• Nov. 5, 2025
SAN FRANCISCO--(BUSINESS WIRE)--UNITY (NYSE: U), THE LEADING PLATFORM TO CREATE AND GROW GAMES AND INTERACTIVE EXPERIENCES, TODAY ANNOUNCED FINANCIAL RESULTS FOR THE THIRD QUARTER ENDED SEPTEMBER 30, 2025. "THIRD-QUARTER RESULTS ONCE AGAIN MEANINGFULLY EXCEEDED EXPECTATIONS ON BOTH REVENUE AND ADJUSTED EBITDA, POWERED BY UNITY VECTOR AI, AS WELL AS CONTINUED STRENGTH IN CREATE. AS CONSUMER ENTHUSIASM FOR INTERACTIVE ENTERTAINMENT CONTINUES TO GROW, UNITY IS POISED TO GROW WITH IT." EARNINGS WEB.
U
• Nov. 5, 2025
NEW YORK--(BUSINESS WIRE)--ACACIA RESEARCH CORPORATION (NASDAQ: ACTG) (“ACACIA” OR THE “COMPANY”), WHICH ACQUIRES AND OPERATES BUSINESSES ACROSS THE INDUSTRIAL, ENERGY AND TECHNOLOGY SECTORS, TODAY REPORTED FINANCIAL RESULTS FOR THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2025. THE COMPANY ALSO POSTED ITS THIRD QUARTER 2025 EARNINGS PRESENTATION ON ITS WEBSITE AT WWW.ACACIARESEARCH.COM UNDER QUARTERLY RESULTS. MARTIN (“MJ”) D. MCNULTY, JR., CHIEF EXECUTIVE OFFICER, STATED, “ACACIA DELIVERED S.
ACTG
• Nov. 5, 2025
PHOENIX--(BUSINESS WIRE)--ALBIREO ENERGY, A LEADING INDEPENDENT PROVIDER OF BUILDING AUTOMATION AND ENERGY SERVICES, TODAY ANNOUNCED THE CONTINUED GROWTH OF ITS ARIZONA DIVISION AND THE APPOINTMENT OF CARLA MILLER AS VICE PRESIDENT AND GENERAL MANAGER, ARIZONA. ALBIREO ENERGY ENTERED THE ARIZONA MARKET THROUGH ITS ACQUISITION OF CONTROL ENGINEERING, A RESPECTED PROVIDER OF BUILDING AUTOMATION AND ENERGY SOLUTIONS SERVING THE REGION FOR DECADES. BUILDING ON THAT STRONG FOUNDATION, ALBIREO ENERGY.
ALBO
• Nov. 5, 2025
FOSTER CITY, CALIF.--(BUSINESS WIRE)--GERON CORPORATION (NASDAQ: GERN), A COMMERCIAL-STAGE BIOPHARMACEUTICAL COMPANY AIMING TO CHANGE LIVES BY CHANGING THE COURSE OF BLOOD CANCER, TODAY REPORTED FINANCIAL RESULTS FOR THE THIRD QUARTER OF 2025 AND RECENT BUSINESS HIGHLIGHTS. "THE HIGH UNMET NEED IN LOWER-RISK MDS IS WELL KNOWN, AND RYTELO IS A THERAPY WITH A NOVEL MECHANISM OF ACTION AND THE POTENTIAL TO SIGNIFICANTLY IMPACT THE TREATMENT PARADIGM. THERE IS WORK AHEAD OF US TO FULLY MAXIMIZE THE.
GERN
• Nov. 5, 2025
WILMINGTON, MASS.--(BUSINESS WIRE)--CHARLES RIVER LABORATORIES ANNOUNCES THIRD-QUARTER 2025 RESULTS.
CRL
• Nov. 5, 2025
JACKSONVILLE, FLA.--(BUSINESS WIRE)--FIS® (NYSE:FIS), A GLOBAL LEADER IN FINANCIAL TECHNOLOGY, TODAY REPORTED ITS THIRD QUARTER 2025 RESULTS. “WE DELIVERED STRONG RESULTS THIS QUARTER WITH DISCIPLINED EXECUTION DRIVING OUTPERFORMANCE AGAINST ALL OF OUR FINANCIAL COMMITMENTS,” SAID FIS CEO AND PRESIDENT STEPHANIE FERRIS. “OUR DIFFERENTIATED POSITIONING WITHIN A FAVORABLE MARKET ENVIRONMENT IS TRANSLATING INTO STRONG SALES PERFORMANCE ACROSS ALL SEGMENTS OF OUR BUSINESS. WE CONTINUE TO ENHANCE OU.
FIS
• Nov. 5, 2025
PHOENIX--(BUSINESS WIRE)--ADESA, A LEADER IN WHOLESALE AUTO AUCTIONS AND A SUBSIDIARY OF LEADING ONLINE AUTO RETAILER CARVANA (NYSE: CVNA), TODAY ANNOUNCED THE EXPANSION OF ITS CARVALUE™ VEHICLE VALUATION GUIDE TO INCLUDE RETAIL MARKET VALUE ESTIMATES AND RETAIL-BID SPREAD CALCULATIONS. THESE UPDATES EMPOWER WHOLESALE BUYERS WITH ADDITIONAL TRANSPARENCY, CONFIDENCE, AND CONVENIENCE WHEN BIDDING ON ADESA'S DIGITAL AUCTION PLATFORM. THIS LAUNCH IS ONE OF MANY RECENT ENHANCEMENTS ADESA HAS MADE AS.
CVNA
• Nov. 5, 2025
FRAMINGHAM, MASS. & SALISBURY, ENGLAND--(BUSINESS WIRE)--KALVISTA PHARMACEUTICALS, INC. (NASDAQ: KALV), TODAY ANNOUNCED THAT THE COMPANY WILL PARTICIPATE IN A FIRESIDE CHAT AT EACH OF THE FOLLOWING UPCOMING INVESTOR CONFERENCES: STIFEL 2025 HEALTHCARE CONFERENCE ON WEDNESDAY, NOVEMBER 12, 2025, AT 8:40 A.M. EST JEFFERIES GLOBAL HEALTHCARE CONFERENCE IN LONDON ON WEDNESDAY, NOVEMBER 19, 2025, AT 1:30 P.M. GMT THE LIVE AUDIO WEBCAST OF EACH PRESENTATION WILL BE ACCESSIBLE ON THE INVESTORS SECTION.
KALV
• Nov. 5, 2025
EXTON, PA.--(BUSINESS WIRE)--BENTLEY SYSTEMS, INCORPORATED (NASDAQ: BSY) TODAY ANNOUNCED RESULTS FOR ITS THIRD QUARTER ENDED SEPTEMBER 30, 2025.
BSY
• Nov. 5, 2025
PALO ALTO, CALIF.--(BUSINESS WIRE)--D-WAVE QUANTUM INC. (NYSE: QBTS) (“D-WAVE”), A LEADER IN QUANTUM COMPUTING SYSTEMS, SOFTWARE, AND SERVICES, AND BASF, ONE OF THE WORLD'S LEADING CHEMICAL COMPANIES, TODAY ANNOUNCED THE COMPLETION OF A JOINT PROOF-OF-CONCEPT PROJECT THAT USED A HYBRID-QUANTUM APPLICATION TO OPTIMIZE MANUFACTURING WORKFLOWS IN A BASF LIQUID-FILLING FACILITY. THE HYBRID-QUANTUM TECHNOLOGY SET A NEW BENCHMARK FOR MANUFACTURING EFFICIENCY, ALLOWING REDUCTION OF PRODUCTION SCHEDULI.
QBTS
• Nov. 5, 2025
SALT LAKE CITY--(BUSINESS WIRE)--REPOSITRAK (NYSE:TRAK), THE WORLD'S LARGEST FOOD TRACEABILITY AND REGULATORY COMPLIANCE NETWORK, LEVERAGING ITS ESTABLISHED INVENTORY MANAGEMENT AND OUT-OF-STOCK REDUCTION SAAS PLATFORM, ANNOUNCES THE ADDITION OF 22 COMPANIES, INCLUDING PRODUCE SUPPLIERS AND PLANT-BASED MEAL PRODUCERS, TO THE REPOSITRAK TRACEABILITY NETWORK®. THESE COMPANIES WILL EFFICIENTLY EXCHANGE INTRICATE, FDA-REQUIRED KEY DATA ELEMENTS (KDES) FOR EACH CRITICAL TRACKING EVENT (CTE) IN THEIR.
TRAK
• Nov. 5, 2025
BURLINGTON, MASS., NOV. 05, 2025 (GLOBE NEWSWIRE) -- FRACTYL HEALTH, INC. (NASDAQ: GUTS) (THE COMPANY), A METABOLIC THERAPEUTICS COMPANY FOCUSED ON PATTERN-BREAKING APPROACHES TO TREAT THE ROOT CAUSES OF OBESITY AND TYPE 2 DIABETES (T2D), TODAY ANNOUNCED IT WILL REPORT FINANCIAL RESULTS FOR THE THIRD QUARTER 2025 AND PROVIDE BUSINESS UPDATES ON WEDNESDAY, NOVEMBER 12, 2025, AT 4:30 P.M. ET.
GUTS
• Nov. 5, 2025
WALTHAM, MASS., NOV. 05, 2025 (GLOBE NEWSWIRE) -- APELLIS PHARMACEUTICALS, INC. (NASDAQ: APLS) TODAY ANNOUNCED THAT THE COMPANY WILL PRESENT AT THE STIFEL 2025 HEALTHCARE CONFERENCE ON WEDNESDAY, NOVEMBER 12, 2025 AT 2:40 P.M. ET.
APLS
• Nov. 5, 2025
BOSTON, NOV. 05, 2025 (GLOBE NEWSWIRE) -- ATEA PHARMACEUTICALS, INC. (NASDAQ: AVIR) (ATEA OR COMPANY), A CLINICAL-STAGE BIOPHARMACEUTICAL COMPANY ENGAGED IN THE DISCOVERY AND DEVELOPMENT OF ORAL ANTIVIRAL THERAPEUTICS FOR SERIOUS VIRAL DISEASES, TODAY ANNOUNCED THAT IT WILL HOST A LIVE CONFERENCE CALL AND AUDIO WEBCAST ON WEDNESDAY, NOVEMBER 12, 2025, AT 4:30 P.M. ET TO REPORT FINANCIAL RESULTS FOR THE THIRD QUARTER ENDED SEPTEMBER 30, 2025, AND TO PROVIDE A BUSINESS UPDATE.
AVIR
• Nov. 5, 2025
FOR AN ACCESSIBLE VERSION OF THIS PRESS RELEASE, PLEASE VISIT WWW.TEVAPHARM.COM TEVA REPORTS REVENUES OF $4.5 BILLION IN THE THIRD QUARTER OF 2025, AN INCREASE OF 3% YEAR-OVER-YEAR (YOY) IN U.S. DOLLARS OR 1% IN LOCAL CURRENCY (LC). EXCLUDING JAPAN BV IN Q3 2024, REVENUES INCREASED 5% IN U.S. DOLLARS OR 3% IN LC.
TEVA
• Nov. 5, 2025
– PHASE 3 LUGANO AND LUCIA CLINICAL TRIALS FOR DURAVYU ™ IN WET AMD FULLY ENROLLED AND ON TRACK FOR DATA READOUT BEGINNING IN MID-2026 –
EYPT
• Nov. 5, 2025
ZUG, SWITZERLAND, NOVEMBER 5, 2025 – MOONLAKE IMMUNOTHERAPEUTICS (NASDAQ: MLTX) (“MOONLAKE” OR THE “COMPANY”), A CLINICAL-STAGE BIOTECHNOLOGY COMPANY FOCUSED ON CREATING NEXT-LEVEL THERAPIES FOR INFLAMMATORY DISEASES, TODAY ANNOUNCED ITS FINANCIAL RESULTS FOR THE THIRD QUARTER OF 2025.
MLTX
• Nov. 5, 2025
CORNELIUS, N.C., NOV. 05, 2025 (GLOBE NEWSWIRE) -- ALPHA MODUS HOLDINGS, INC. (NASDAQ: AMOD) SUBSIDIARY ALPHA MODUS, CORP. ANNOUNCED THAT IT HAS FILED A FEDERAL PATENT-INFRINGEMENT LAWSUIT IN THE U.S. DISTRICT COURT FOR THE CENTRAL DISTRICT OF CALIFORNIA AGAINST ADROIT WORLDWIDE MEDIA, INC. (“AWM”), ALLEGING UNAUTHORIZED USE OF ALPHA MODUS'S PATENTED RETAIL-INTELLIGENCE AND CASHIERLESS-CHECKOUT TECHNOLOGIES.
AMOD
• Nov. 5, 2025
VANCOUVER, BRITISH COLUMBIA, NOV. 05, 2025 (GLOBE NEWSWIRE) -- NEVGOLD CORP. (“NEVGOLD” OR THE “COMPANY”) ( TSXV:NAU) (OTCQX:NAUFF) (FRANKFURT:5E50) IS PLEASED TO ANNOUNCE FURTHER POSITIVE ANTIMONY (“ANTIMONY”, “SB”) METALLURGICAL TESTWORK RESULTS AT ITS OXIDE GOLD-ANTIMONY LIMOUSINE BUTTE PROJECT (THE “PROJECT”, “LIMO BUTTE”) IN NEVADA, ONE OF THE WORLD'S PROLIFIC MINING JURISDICTIONS.
NAUFF
• Nov. 5, 2025
– POSITIVE TOP-LINE RESULTS FROM VIBRANT PHASE 2 TRIAL OF VEREKITUG IN CRSWNP REPORTED IN SEPTEMBER SHOWED STATISTICALLY SIGNIFICANT AND CLINICALLY MEANINGFUL EFFECTS ON PRIMARY AND KEY SECONDARY ENDPOINTS WHEN ADMINISTERED ONCE EVERY 12 WEEKS –
UPB
• Nov. 5, 2025
BOSTON AND LONDON, NOV. 05, 2025 (GLOBE NEWSWIRE) -- CENTESSA PHARMACEUTICALS PLC (NASDAQ: CNTA), A CLINICAL-STAGE PHARMACEUTICAL COMPANY, TODAY REPORTED FINANCIAL RESULTS FOR THE THIRD QUARTER ENDED SEPTEMBER 30, 2025 AND PROVIDED AN UPDATE ON ITS OX2R AGONIST PROGRAM, INCLUDING PHASE 2A DATA1 FROM THE INITIAL DOSING COHORTS WITHIN THE ONGOING CRYSTAL-1 STUDY OF ORX750 IN NT1, NT2 AND IH PARTICIPANTS, AND PHASE 1 DATA2 FROM THE ONGOING STUDY OF ORX142 IN HEALTHY VOLUNTEERS.
CNTA
• Nov. 5, 2025
